Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMO, the unprecedented determination of some, who obviously know and understand a great deal about possible cancer treatments, must be greatly threatened by how close PMCB is to being the proving ground for new treatments. I dont get it?, the only other explanation could be that some would have a very large PMCB short position.
Could this be the time? is PMCB close?
Look at a stone cutter hammering away at his rock, perhaps a hundred times without as much as a crack showing in it. Yet at the hundred-and-first blow it will split in two, and I know it was not the last blow that did it, but all that had gone before." - Jacob A. Riis
Good Luck to all longs, have a wonderful weekend.
I think you need to get the volume up to around 5 million per day then were talking.
You guys gotta put in about 20k is all, to get this up, come on dont give up now
The immunotherapy that will be reporting early results for PC in about a week, IMO there is a high probability that the results will be so inconsistent, because the immune systems of various patients cannot be determined, the therapy will not prove to be a reliable therapy for cancer, cell in a box, pmcb, INDY will be the proving ground for the future, and more money will be funneled away from immunotherapy.
picked up some more, ready, waiting, and loaded, for the kaboom time
LOL go pmcb
I agree
lets see how volume is once ind is submitted, Kaboom
it is essential that the ifosfamide can easily and quickly enter the capsules so that it can be efficiently converted into the ifosfamide tumor-killing metabolite. It is equally important that this metabolite can then exit the capsules and destroy the tumor. The completed studies clearly demonstrate that this is the case and underscore the stability of the capsules over the freezing, transport and storage cycle.”
As part of PharmaCyte’s Investigational New Drug Application (IND) for its clinical trial in patients with LAPC, the FDA required PharmaCyte to provide data showing that the size of the pores in the outer shell of the Cell-in-a-Box® capsules is appropriate to allow ifosfamide to enter the interior of the capsules where the ifosfamide-activating cells are located. Additionally, PharmaCyte is required to provide data showing that the pores are also of appropriate size to allow the activated form of ifosfamide to leave the capsules.
immuno therapy drugs, can cause your immune system to attack organs like your heart, liver, lungs, kidneys, or intestines.
I respectfully very highly disagree
we will see, you never know, but id rather take my chances here, than loto tickets, good luck.
If you are even correct it does not matter this will be the proving ground for breakthrough technology for all types of cancer
That is only your opinion?
yes, do not invest, if you dont understand, buffet is right, then again he probably never buys lottery tickets, tell that to the next lottery winner.
The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide flows through pores in the capsules, the live cells inside act as a “bio-artificial liver” and activate the chemotherapy drug at the site of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no treatment related side effects.
Immuno therapy Everybody's immune system is different, the difficulty will always be there, to much, not good, not enough not good, the challenges are insurmountable.
We are about to find that out who is right who is wrong
Very low dose, unlike the dangers of immuno therapy can do to the system
Cell therapy will be the future, and pmcb is leading they way it had to start somewhere.
I total agree 100%, could be BEAR market for immuno therapy funding. Immuno therapy will now have major competition, IMO funding will flow into cell therapy, pmcb is the only company that can produce large amounts of cells, freeze, and store the cells, to be used to target many diseases.
The data from testing of a run, (only need 1 of the runs for that data) that produces positive results, (Gunzburg says we have an excellent product now) once they have that data it will be incorporated into the INDI Application IT IS THE FINAL PIECE
Sounds like PMCB is about to redirect the money flow, and funding, from immune therapies into a whole new future, of cell encapsulation technology. That is what I believe.
That is because pmcb is the only one that can encapsulate the cells, immuno has many problems and imo can not be as safe as cell in a box
You cant possibly know what Hidalgo thinks of PMCB
That was in January, so your cherry picking.
yes me too, still not sure because I just noticed KW has the same clothes and same ugly tie, on from posts that were from June 13th so they were all taken the same day but posted at different times so who know.
this post was yesterday at 3:30 am so it looks like they are still there
PharmaCyte’s CEO, Kenneth L. Waggoner, and consulting cellular biologist, David A. Judd, continue to work with Austrianova’s Walter H. Gunzburg and Brian Salmons and their team as the production of PharmaCyte's clinical trial material is center stage at the facility.
No photo description available. they are posting pictures from visit so could be past tense not sure, but I think they are still there
going to the moon, cell phones, was mythical at one point in time too, never give up, go PMCB
hopefully it doesn't prevent him from filling, your talking about something that hasn't happened yet, you dont know if it will, or wont happen,,it is mythical ( in your words) till it actually happens then what will you call it?
What does everyone think? does big pharma go as far as to pay individuals to spread negative, false, cherry picked roomers, about promising new companies such as PMCB because they feel threatened that maybe just maybe they could take a huge bite out of there profits.
PMCB could be a threat to big pharma.
Ive been trying to back track and find it but cant yet
3 for 1 doesn't sound right ?
Not sure, but the company gave us shares based on how many we owned at that time, cant remember what the formula was or what they called it,maybe something like a stock split, 1000 to 1 ? i dont remember
I agree annoying to me also
I added today also, got my average down to .07 now, I am good with that.
When Martin Schmieg was ceo for nvlx the company gave you those shares based on how many shares you owned at that time, you got them for FREE, when PMCB makes it big you will be able to cash them in. Those shares are restricted until PMCB decides to unrestrict them because they were free
I have some of those shares but they dont amount to enough to worry about, they will probably remain restricted until pmcb goes kaboom